Search for: "Astrazeneca"
Results 361 - 380
of 1,244
Sorted by Relevance
|
Sort by Date
6 Jul 2017, 8:21 am
The Supreme Court of Canada issued a ruling in AstraZeneca Canada Inc. v. [read post]
26 Sep 2011, 7:05 am
AstraZeneca’s patent on the brand-name product expires on 09/26/11. [read post]
30 Sep 2021, 1:22 pm
CBMG Holdings, a Cayman Island biopharmaceutical company that operates a manufacturing facility in Rockville for the development of cellular immunotherapies for the treatment of cancer and degenerative diseases, Thursday announced the closing of a $120 million Series A investment, led by AstraZeneca-CICC Fund, Sequoia Capital China and Yunfeng Capital. [read post]
20 Jan 2008, 6:55 pm
AstraZeneca AB et al. v. [read post]
27 Dec 2013, 4:55 am
AstraZeneca Loses at the Federal Circuit on Omeprazole. [read post]
23 Jan 2017, 2:15 pm
Bahija Jallal, PhD, an executive vice president with AstraZeneca and head of Gaithersburg-based MedImmune, was named 2017 Woman of the Year by The Healthcare Businesswomen’s Association. [read post]
1 Dec 2016, 7:24 am
MBBP’s client Abpro, a pioneer in the field of industrial biochemistry, has recently entered into a Collaboration Agreement with MedImmune, the global biologics research and development arm of AstraZeneca. [read post]
30 Sep 2010, 8:53 am
In February, the University of Pennsylvania (Penn) and AstraZeneca forged a new collaborative research agreement, featuring a significant licensing component, that makes use of their respective talents and resources to generate new Alzheimer’s Disease (AD) drug candidates for the clinical development pipeline. [read post]
22 Dec 2009, 10:08 am
Investigations and eventual settlements with Tap Pharmaceuticals ($875 million) and AstraZeneca ($350 million) paved the way for compliance guidance by CMS Office of Inspector General (OIG) published in 2003. [read post]
4 Nov 2010, 6:14 am
In Astrazeneca v. [read post]
19 Oct 2006, 11:53 am
.'s and last but not the least AstraZeneca PLC's. [read post]
20 Dec 2012, 12:20 pm
The short version is that Astrazeneca has won for the time being: the Federal Circuit ruled in favor of Astrazeneca on all issues. [read post]
5 Dec 2011, 9:59 pm
In Ranbaxy (UK) Ltd v AstraZeneca AB, the England and Wales High Court considered the scope of "Swiss" medical use claims. [read post]
8 Oct 2009, 11:06 am
According to Bloomberg News, the drug company, AstraZeneca, advised its sales department to continue promoting a popular antipsychotic drug, Seroquel, as "weight neutral. [read post]
20 Jul 2011, 3:43 am
The New York Times reports that “AstraZeneca is adding a new heart warning to the labels of Seroquel [quetiapine], its blockbuster antipsychotic drug, at the request of the Food and Drug Administration, company and agency officials said on Monday. [read post]
21 May 2015, 7:10 am
Bloomberg News reports that the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended that the agency “add data from trials on the heart effects to the labels of” two diabetes drugs: AstraZeneca’s Onglyza (saxagliptin) and Takeda’s Nesina (alogliptin). [read post]
10 Nov 2008, 2:12 am
THIS SOUNDS LIKE GOOD NEWS: "AstraZeneca Plc's Crestor slashed the risk of heart attack, stroke and death by nearly half in people with normal or low cholesterol in a study, potentially opening a way to save the lives of thousands of seemingly healthy people. [read post]
AN ADMISSION OF DEFEAT? “Announcing layoffs along with a stock buyback – let’s think about what tha…
9 Feb 2012, 10:00 am
AstraZeneca did that just the other day, and they’re far from the only ones in this industry (or others) spending billions to buy back their own shares while they’re cutting costs elsewhere.” Plus: “Here we have all these companies obsessed, basically with keeping their stock prices up, and saying the best thing that they can do with their money is spend billions of dollars on stock. [read post]
27 Jan 2017, 12:00 pm
George Mullen brought the complaint against Nexium manufacturer AstraZeneca Pharmaceuticals in the U.S. [read post]
21 Apr 2017, 4:21 am
Anders ValentinOn 17 June 2016 the Maritime and Commercial court declared AstraZeneca’s patent DK/EP 0 907 364 invalid, rendering the preliminary injunctions granted against Teva and a number of other competitors void as a result. [read post]
